Related Experiment Video
Updated: Jan 1, 2026

Assessment of Plasma Coagulation on Liver Tissue in a Large Animal Model In Vivo
Published on: August 4, 2018
Marked coagulopathy without liver disease or anticoagulation therapy
Kevin Jurgensmeier1, Lee J Hixson2, David C Pfeiffer3
1WWAMI Medical Education Program, University of Washington School of Medicine and the University of Idaho, 875 Perimeter Drive, Moscow, ID, 83844, USA.
Celiac disease (CD) can rarely cause severe bleeding disorders. Prompt diagnosis and treatment of CD in patients with unexplained coagulopathy are crucial for patient safety and recovery.
Area of Science:
- Gastroenterology
- Hematology
- Internal Medicine
Background:
- Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion, primarily affecting the small intestine.
- While malabsorption is common, symptomatic coagulopathies are rare presentations of CD.
Observation:
- A 66-year-old female presented with severe bleeding symptoms, including ecchymoses and melena, and profound coagulopathy (PTT >200s, PT >150s, INR 20.5).
- Initial investigations revealed severe anemia and vitamin D deficiency, with no evidence of liver disease or anticoagulant use.
- Endoscopic findings showed duodenal mucosal atrophy, gastritis, and villous flattening, with positive transglutaminase serology confirming CD.
Findings:
- The patient's coagulopathy resolved rapidly within two days of treatment with fresh frozen plasma, packed red cells, and intravenous vitamin K.
- Histopathological examination confirmed celiac disease, characterized by villous atrophy and intraepithelial lymphocytes.
Implications:
- This case highlights the critical importance of considering celiac disease in the differential diagnosis of unexplained coagulopathies, even in the absence of typical gastrointestinal symptoms.
- Early identification and management of CD can prevent life-threatening hemorrhagic complications.
More Related Videos
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

